• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D异构体的应用及新型治疗药物合成类似物研发的最新进展

Recent Advancements Towards the Use of Vitamin D Isoforms and the Development of Their Synthetic Analogues as New Therapeutics.

作者信息

Patel Rajiv, Kharkwal Harsha, Saha Moumita, Sankaranarayanan Murugesan, Sharma Saurabh, Chander Subhash

机构信息

Amity Institute of Phytochemistry & Phytomedicine, Amity University Uttar Pradesh, Noida 201313, India.

Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida 201313, India.

出版信息

Biomedicines. 2025 Apr 21;13(4):1002. doi: 10.3390/biomedicines13041002.

DOI:10.3390/biomedicines13041002
PMID:40299638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12025311/
Abstract

Vitamin D and its metabolites are essential in various physiological processes, including muscle strength, metabolism, antifibrotic activity, and immune regulation. Researchers are focusing on developing vitamin D derivatives with optimized receptor selectivity and reduced systemic toxicity, enhancing their therapeutic efficacy against cancer, autoimmune disorders, and inflammatory diseases. Several analogues, such as alfacalcidol, paricalcitol, and falecalcitriol, are used for managing CKD-related bone disorders, while eldecalcitol is effective for osteoporosis, and calcipotriol against psoriasis. Recent studies have explored their impact on metabolic pathways, parathyroid hormone secretion, asthma, and liver fibrosis, revealing their broad clinical potential. Despite enormous efforts in the past decades, translations of vitamin D-drugs are disproportionately limited, mainly due to toxicity due to calcemic effects and undesirable metabolic profile. This review discusses structural modifications in vitamin D3, their influence on VDR binding, transcriptional activity, and calcium homeostasis, along with their role in targeting pathways like EGFR, KRAS, and Hedgehog in cancers. Advanced analytical techniques such as LC/ESI-MS/MS facilitate precise detection of vitamin D metabolites, further improving pharmacokinetic profiling. Future research may enable the clinical approval of novel vitamin D-based therapeutics with minimal disruption to calcium-phosphorus balance.

摘要

维生素D及其代谢产物在多种生理过程中至关重要,包括肌肉力量、新陈代谢、抗纤维化活性和免疫调节。研究人员正致力于开发具有优化受体选择性和降低全身毒性的维生素D衍生物,以提高其对癌症、自身免疫性疾病和炎症性疾病的治疗效果。几种类似物,如阿法骨化醇、帕立骨化醇和度骨化醇,用于治疗与慢性肾脏病相关的骨疾病,而依替膦酸二钠对骨质疏松症有效,卡泊三醇对银屑病有效。最近的研究探讨了它们对代谢途径、甲状旁腺激素分泌、哮喘和肝纤维化的影响,揭示了它们广泛的临床潜力。尽管在过去几十年中付出了巨大努力,但维生素D药物的转化却极其有限,主要是由于其钙血症效应导致的毒性和不良的代谢特征。本综述讨论了维生素D3的结构修饰、它们对维生素D受体结合、转录活性和钙稳态的影响,以及它们在癌症中靶向表皮生长因子受体、KRAS和刺猬信号通路等途径中的作用。先进的分析技术,如液相色谱/电喷雾串联质谱,有助于精确检测维生素D代谢产物,进一步改善药代动力学特征。未来的研究可能会使新型维生素D类疗法在对钙磷平衡干扰最小的情况下获得临床批准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/ee5b82a0da01/biomedicines-13-01002-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/07a37db64a55/biomedicines-13-01002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/9d59e43d6dd0/biomedicines-13-01002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/66f45a1dc615/biomedicines-13-01002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/d5852a53ecd8/biomedicines-13-01002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/27819ed6ff13/biomedicines-13-01002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/ae77157eaf70/biomedicines-13-01002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/8c7a46b51697/biomedicines-13-01002-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/0f081ec19008/biomedicines-13-01002-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/40bb8a1f949d/biomedicines-13-01002-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/f6be7e9aafed/biomedicines-13-01002-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/8418b79bd731/biomedicines-13-01002-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/8009224c2283/biomedicines-13-01002-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/9fd85595f272/biomedicines-13-01002-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/ee5b82a0da01/biomedicines-13-01002-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/07a37db64a55/biomedicines-13-01002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/9d59e43d6dd0/biomedicines-13-01002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/66f45a1dc615/biomedicines-13-01002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/d5852a53ecd8/biomedicines-13-01002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/27819ed6ff13/biomedicines-13-01002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/ae77157eaf70/biomedicines-13-01002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/8c7a46b51697/biomedicines-13-01002-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/0f081ec19008/biomedicines-13-01002-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/40bb8a1f949d/biomedicines-13-01002-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/f6be7e9aafed/biomedicines-13-01002-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/8418b79bd731/biomedicines-13-01002-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/8009224c2283/biomedicines-13-01002-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/9fd85595f272/biomedicines-13-01002-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/12025311/ee5b82a0da01/biomedicines-13-01002-g014.jpg

相似文献

1
Recent Advancements Towards the Use of Vitamin D Isoforms and the Development of Their Synthetic Analogues as New Therapeutics.维生素D异构体的应用及新型治疗药物合成类似物研发的最新进展
Biomedicines. 2025 Apr 21;13(4):1002. doi: 10.3390/biomedicines13041002.
2
Vitamin D receptor as a drug discovery target.维生素D受体作为药物研发靶点。
Mini Rev Med Chem. 2003 May;3(3):193-204. doi: 10.2174/1389557033488204.
3
Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.3-羟丙氧基的多功能和强效作用为 eldecalcitol 在骨质疏松症治疗中的益处提供了保障。
J Steroid Biochem Mol Biol. 2014 Jan;139:88-97. doi: 10.1016/j.jsbmb.2013.10.007. Epub 2013 Oct 16.
4
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病(未透析)患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
5
Therapeutic uses of vitamin D analogues.维生素D类似物的治疗用途。
Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S3-S19. doi: 10.1053/ajkd.2001.28111.
6
Vitamin D analogues.维生素D类似物
Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S25-39. doi: 10.1053/ajkd.1998.v32.pm9808141.
7
Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.维生素D类似物对培养的结肠直肠癌的不同抗肿瘤作用。
Int J Oncol. 2015 Sep;47(3):1084-96. doi: 10.3892/ijo.2015.3088. Epub 2015 Jul 17.
8
D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol.D-激素衍生物在骨质疏松症治疗中的应用:从阿法骨化醇到骨化三醇。
Mini Rev Med Chem. 2009 Oct;9(12):1416-22. doi: 10.2174/138955709789957486.
9
Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands.合成维生素D受体配体对炎症性肠病和结直肠癌的控制
Curr Med Chem. 2017;24(9):868-875. doi: 10.2174/0929867323666161202145509.
10
Eldecalcitol reduces osteoporotic fractures by unique mechanisms.eldecalcitol 通过独特机制减少骨质疏松性骨折。
J Steroid Biochem Mol Biol. 2015 Apr;148:232-8. doi: 10.1016/j.jsbmb.2015.01.016. Epub 2015 Jan 24.

引用本文的文献

1
Hypovitaminosis D Does Not Aggravate the Progression of Gentamicin-Induced Kidney Injury in Rats.维生素D缺乏不会加重庆大霉素诱导的大鼠肾损伤进展。
Diseases. 2025 Jun 28;13(7):200. doi: 10.3390/diseases13070200.

本文引用的文献

1
Targeting Calcitriol Metabolism in Acute Vitamin D Toxicity-A Comprehensive Review and Clinical Insight.靶向急性维生素 D 毒性中的钙三醇代谢:全面综述和临床观察。
Int J Mol Sci. 2024 Sep 17;25(18):10003. doi: 10.3390/ijms251810003.
2
A randomized controlled trial of the effect of raloxifene plus cholecalciferol versus cholecalciferol alone on bone mineral density in postmenopausal women with osteopenia.雷洛昔芬加胆钙化醇与单用胆钙化醇对绝经后骨质减少女性骨密度影响的随机对照试验。
JBMR Plus. 2024 May 30;8(7):ziae073. doi: 10.1093/jbmrpl/ziae073. eCollection 2024 Jul.
3
Effects of active vitamin D analogues on muscle strength and falls in elderly people: an updated meta-analysis.
活性维生素 D 类似物对老年人肌肉力量和跌倒的影响:一项更新的荟萃分析。
Front Endocrinol (Lausanne). 2024 Feb 1;15:1327623. doi: 10.3389/fendo.2024.1327623. eCollection 2024.
4
Efficacy and safety of single or consecutive double high-dose oral cholecalciferol supplementation in adult patients with vitamin D deficiency.单次或连续两次高剂量口服胆钙化醇补充剂对维生素D缺乏成年患者的疗效和安全性
Steroids. 2023 Nov;199:109308. doi: 10.1016/j.steroids.2023.109308. Epub 2023 Sep 4.
5
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration.维生素D,一种类固醇激素及其多功能受体——维生素D受体,与阿尔茨海默病型神经退行性变
J Alzheimers Dis. 2023;95(4):1273-1299. doi: 10.3233/JAD-230214.
6
Syntheses of 25-Adamantyl-25-alkyl-2-methylidene-1α,25-dihydroxyvitamin D Derivatives with Structure-Function Studies of Antagonistic and Agonistic Active Vitamin D Analogs.25-金刚烷基-25-烷基-2-亚甲基-1α,25-二羟基维生素 D 衍生物的合成及其拮抗和激动型活性维生素 D 类似物的构效关系研究。
Biomolecules. 2023 Jul 6;13(7):1082. doi: 10.3390/biom13071082.
7
Cancer incidence and mortality trends in Asia based on regions and human development index levels: an analyses from GLOBOCAN 2020.亚洲地区基于区域和人类发展指数水平的癌症发病和死亡趋势:基于 GLOBOCAN 2020 的分析。
Curr Med Res Opin. 2023 Aug;39(8):1127-1137. doi: 10.1080/03007995.2023.2231761. Epub 2023 Jul 17.
8
Calcium, zinc, and vitamin D in breast milk: a systematic review and meta-analysis.母乳中的钙、锌和维生素 D:系统评价和荟萃分析。
Int Breastfeed J. 2023 Jun 1;18(1):27. doi: 10.1186/s13006-023-00564-2.
9
Vitamin D and Autoimmune Rheumatic Diseases.维生素 D 与自身免疫性风湿病
Biomolecules. 2023 Apr 21;13(4):709. doi: 10.3390/biom13040709.
10
The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases.维生素 D 及其结合蛋白在慢性肝病中的作用。
Int J Mol Sci. 2022 Sep 14;23(18):10705. doi: 10.3390/ijms231810705.